Cann Group Gestion

Gestion contrôle des critères 1/4

Le PDG Cann Group est Jenni Pilcher, nommé en Apr2024, a un mandat de moins d'un an. La rémunération annuelle totale est A$ 607.40K, composée du salaire de 26.9% et des bonus 73.1%, y compris les actions et options de la société. détient directement 0.07% des actions de la société, d'une valeur de A$ 15.53K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 0.6 ans et 3.2 ans.

Informations clés

Jenni Pilcher

Directeur général

AU$607.4k

Rémunération totale

Pourcentage du salaire du PDG	26.9%
Durée du mandat du directeur général	less than a year
Propriété du PDG	0.07%
Durée moyenne d'occupation des postes de direction	less than a year
Durée moyenne du mandat des membres du conseil d'administration	3.2yrs

Mises à jour récentes de la gestion

Recent updates

Cann Group Limited's (ASX:CAN) Price Is Right But Growth Is Lacking After Shares Rocket 36%

Sep 24

Shareholders May Be A Bit More Conservative With Cann Group Limited's (ASX:CAN) CEO Compensation For Now

Nov 03

Here's Why We're Not Too Worried About Cann Group's (ASX:CAN) Cash Burn Situation

Feb 23

What Type Of Returns Would Cann Group's(ASX:CAN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Nov 25

One Forecaster Is Now More Bearish On Cann Group Limited (ASX:CAN) Than They Used To Be

Nov 25

Analyse de la rémunération des PDG

Comment la rémunération de Jenni Pilcher a-t-elle évolué par rapport aux bénéfices de Cann Group?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	AU$607k	AU$163k	-AU$51m
Mar 31 2024	n/a	n/a	-AU$40m
Dec 31 2023	n/a	n/a	-AU$29m
Sep 30 2023	n/a	n/a	-AU$32m
Jun 30 2023	AU$80k	n/a	-AU$34m
Mar 31 2023	n/a	n/a	-AU$35m
Dec 31 2022	n/a	n/a	-AU$37m
Sep 30 2022	n/a	n/a	-AU$32m
Jun 30 2022	AU$78k	n/a	-AU$26m
Mar 31 2022	n/a	n/a	-AU$25m
Dec 31 2021	n/a	n/a	-AU$24m
Sep 30 2021	n/a	n/a	-AU$25m
Jun 30 2021	AU$62k	n/a	-AU$25m

Rémunération vs marché: La rémunération totale de Jenni ($USD 399.18K ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Australian ($USD 299.68K ).

Rémunération et revenus: La rémunération de Jenni a augmenté alors que l'entreprise n'est pas rentable.

PDG

Jenni Pilcher

less than a year

Titularisation

AU$607,397

Compensation

Mrs. Jennifer Lee Pilcher, CA, BBS, AGIA, ACIS, also known as Jenni, is CEO & MD of Cann Group Limited since April 1, 2024 and serves as its Executive Director since February 2024 and was its Non-Executive...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Jennifer Pilcher	CEO, MD & Executive Director	less than a year	AU$607.40k	0.070% A$ 15.5k
David Hine	Head of Finance	less than a year	pas de données	pas de données
Steven Notaro	Head of Legal and Regulatory Affairs & Company Secretary	less than a year	AU$204.01k	pas de données

0.6yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de CAN n'est pas considérée comme expérimentée (ancienneté moyenne 0.6 ans), ce qui suggère une nouvelle équipe.

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Jennifer Pilcher	CEO, MD & Executive Director	4.2yrs	AU$607.40k	0.070% A$ 15.5k
Douglas Rathbone	Independent Non-Executive Director	9.7yrs	AU$65.00k	0.77% A$ 169.0k
Julian Chick	Non-Executive Chairman	2.1yrs	AU$111.67k	0.053% A$ 11.7k
Robert Barnes	Non-Executive Director	2.2yrs	AU$65.00k	0.043% A$ 9.4k

3.2yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: Les membres du conseil d'administration de CAN sont considérés comme expérimentés (ancienneté moyenne 3.2 ans).

Cann Group Gestion

Gestion contrôle des critères 1/4

Informations clés

Mises à jour récentes de la gestion

Cann Group Limited, Annual General Meeting, Oct 28, 2024

Cann Group Limited Appoints Jenni Pilcher as Managing Director

Less than half of directors are independent

Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs

Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023

Cann Group Limited, Annual General Meeting, Oct 26, 2023

Recent updates

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 6.252486 million.

Cann Group Limited's (ASX:CAN) Price Is Right But Growth Is Lacking After Shares Rocket 36%

Cann Group Limited, Annual General Meeting, Oct 28, 2024

Full year 2024 earnings released: AU$0.12 loss per share (vs AU$0.091 loss in FY 2023)

Cann Group Limited to Report Fiscal Year 2024 Results on Aug 30, 2024

Cann Group Limited Appoints Jenni Pilcher as Managing Director

Less than half of directors are independent

Cann Group Limited's (ASX:CAN) Low P/S No Reason For Excitement

New major risk - Financial position

Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs

A Piece Of The Puzzle Missing From Cann Group Limited's (ASX:CAN) Share Price

Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.3756 million.

Cann Group Limited, Annual General Meeting, Oct 26, 2023

Full year 2023 earnings released: AU$0.091 loss per share (vs AU$0.079 loss in FY 2022)

New minor risk - Financial data availability

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 11.658446 million.

Cann Group Limited Provides Revenue Guidance for the Year Ended June 30, 2023

Cann Group (ASX:CAN) Is Making Moderate Use Of Debt

First half 2023 earnings released: AU$0.053 loss per share (vs AU$0.028 loss in 1H 2022)

Cann Group Limited Announces Preliminary Results from Their Phase 3 Clinical Trail

Cann Group Limited Announces Chief Executive Officer Changes

Cann Group Limited Announces Final Clinical Trial Participant Completes Study

Less than half of directors are independent

Cann Group Limited Appoints Julian John Chick as Director

Cann Group Limited Announces Resignation of Peter Crock as CEO

Cann Group Limited Meets its Enrolment Target for Phase III Clinical Trial of Low-Dose Satipharm CBD Capsules for Short-Term Sleep Disturbance

Cann Group Limited Announces Executive Changes

Cann Group Limited Appoints Robert Barnes & Julian Chick to the Board

Cann Group Limited Announces Resignation of John Sharman as Director

Cann Group Limited, Annual General Meeting, Oct 25, 2022

Full year 2022 earnings released: AU$0.079 loss per share (vs AU$0.098 loss in FY 2021)

Cann Group Limited Announce Therapeutic Goods Administration Grants Cann GMP License to Manufacture Therapeutic Goods

Cann Group Limited Receives Second Payment from Victorian Government's Regional Jobs Fund Program

Less than half of directors are independent

Office of Drug Control Grants Permit for Manufacture of Medicinal Cannabis Products to Cann Group Limited

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Cann Group Limited Announces Resignation of Mr. Geoffrey Pearce as Non-Executive Director

Cann Group Limited Announces Cann to Begin Recruitment for CBD Phase 3 Clinical Trial

Rua Bioscience Limited (NZSE:RUA) agreed to acquire 8.36% stake in Zalm Therapeutics Ltd from Cann Group Limited (ASX:CAN) for NZD 10 million.

Shareholders May Be A Bit More Conservative With Cann Group Limited's (ASX:CAN) CEO Compensation For Now

Chief Financial Officer Greg Bullock has left the company

Full year 2021 earnings released: AU$0.097 loss per share (vs AU$0.12 loss in FY 2020)

Cann Group Limited Revises Revenue Guidance for the Year 2021

Cann Group Limited (ASX:CAN) completed the acquisition of Satipharm Ltd, Satipharm AG and Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT)

Cann Group Limited, Olivia Newton-John Cancer Research Institute and Austin Health Partnered in A Clinical Tria to Assess Medicinal Cannabis for Symptom Management in People with Advanced Cancer

Cann Group Limited (ASX:CAN) entered into a definitive sale agreement to acquire Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT).

First half 2021 earnings released: AU$0.05 loss per share (vs AU$0.06 loss in 1H 2020)

Here's Why We're Not Too Worried About Cann Group's (ASX:CAN) Cash Burn Situation

Cann Group Limited (ASX:CAN) signed a share sale agreement to acquire Satipharm Ltd from Harvest One Cannabis Inc. (TSXV:HVT) for CAD 4 million.

New 90-day high: AU$0.78

Australis Capital Inc. and Cann Group Limited Sign Agreement

Price target lowered to AU$1.12

Cann Group Limited Receives Initial 19,000 Unit Order for Europe

What Type Of Returns Would Cann Group's(ASX:CAN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

One Forecaster Is Now More Bearish On Cann Group Limited (ASX:CAN) Than They Used To Be

Analysts update estimates

New 90-day high: AU$0.51

Deputy Chairman recently bought AU$55k worth of stock

An unknown buyers acquired 11.84% stake in Cann Group Limited (ASX:CAN) from Aurora Cannabis Inc. (TSX:ACB).

New 90-day low: AU$0.38

Cann Group Limited(ASX:CAN) dropped from S&P Global BMI Index

Deputy Chairman recently bought AU$79k worth of stock

Full year earnings released - AU$0.12 loss per share

New 90-day low - AU$0.45

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 25.9 million.

New 90-day low - AU$0.46

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 14.3 million.

New 90-day low - AU$0.72